Drug Research
U.S. FDA approves rivaroxaban to help prevent blood clots in acutely ill medical patients
Bayer AG and its development partner Janssen Research & Development, LLC announced that the U.S. FDA has approved rivaroxaban (Xarelto) for the prevention of venous thromboembolism (VTE), or blood clots, in acutely ill medical patients at risk for thromboembolic...
Drug Research
Arctoris Ltd Secures Seed Funding of £3.2 Million to Advance Novel Drug Discovery Platform Powered by Robotics
Arctoris Ltd, a fully automated drug discovery platform for virtual and traditional biotechnology companies, pharmaceutical corporations and academia, announced that it has successfully closed a seed funding round of £3.2 million to advance its novel drug discovery offering.
The funding...
Drug Research
Novel silica delivery system Nuvec (R) enters final pre-clinical development stage
N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company, has announced results fromthe company’s latest research study into its novel silica nanoparticle for cancer treatments and vaccines, Nuvec®. The work, which repeated and expanded on a previouspDNA OVA study,...
Drug Research
Sygnature Discovery moves US base to Kendall Square
Sygnature Discovery, the leading independent drug discovery and pre-clinical services company, has announced its US office has moved. The new office, at 245 First Street in Cambridge, MA, is near Kendall Square, the heart of the Cambridge–Boston biotech hub.
It’s...
Drug Research
The rise and rise of Global Pharma Excipients Market
With the rise in the Global Pharma Industry, excipients too are bound to have their share of light. Of late, there has been an increasing demand for generic drugs which has, in turn, led to a rise of the...
Drug Research
Sygnature Discovery develops AR molecular visualisation prototype
The space occupied by a drug molecule in three dimensions, and how it fits into the target, is an important consideration when designing a new compound that might become a drug. Medicinal chemists commonly use 3D rendering software to...
Drug Research
Signant Health Brings Its eConsent Solution to China for Large Neuroscience Study in Collaboration with Shanghai Mental Health Center
Signant Health (formerly CRF Health and Bracket), a leading patient-centric technology company, has been selected to provide electronic informed consent for a significant neuroscience study by the prestigious Shanghai Mental Health Center (SMHC). This landmark investigator-led Schizophrenia trial, which...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read